Growing community of inventors

Iowa City, IA, United States of America

Nicholas Baumhover

Average Co-Inventor Count = 5.52

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Nicholas BaumhoverMichael K Schultz (2 patents)Nicholas BaumhoverMengshi Li (2 patents)Nicholas BaumhoverDongyoul Lee (2 patents)Nicholas BaumhoverMichael K Schultz (1 patent)Nicholas BaumhoverF Christoper Pigge (1 patent)Nicholas BaumhoverBrianna S Cagle (1 patent)Nicholas BaumhoverSamuel Rodman, Iii (1 patent)Nicholas BaumhoverMengshi Li (1 patent)Nicholas BaumhoverDijie Liu (1 patent)Nicholas BaumhoverF Christopher Pigge (1 patent)Nicholas BaumhoverIvy Vance (1 patent)Nicholas BaumhoverNicholas Baumhover (3 patents)Michael K SchultzMichael K Schultz (11 patents)Mengshi LiMengshi Li (5 patents)Dongyoul LeeDongyoul Lee (4 patents)Michael K SchultzMichael K Schultz (2 patents)F Christoper PiggeF Christoper Pigge (1 patent)Brianna S CagleBrianna S Cagle (1 patent)Samuel Rodman, IiiSamuel Rodman, Iii (1 patent)Mengshi LiMengshi Li (1 patent)Dijie LiuDijie Liu (1 patent)F Christopher PiggeF Christopher Pigge (1 patent)Ivy VanceIvy Vance (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Iowa Research Foundation (2 from 906 patents)

2. Perspective Therapeutics, Inc. (1 from 2 patents)


3 patents:

1. 12514938 - Fibroblast activation protein targeting peptides

2. 12502442 - Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers

3. 12337042 - Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/19/2026
Loading…